|
1. |
Progesterone Metabolite Allopregnanolone in Women With Premenstrual Syndrome |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 709-714
ANDREA RAPKIN,
MELINDA MORGAN,
LINDA GOLDMAN,
DARRELL BRANN,
DEBORAH SIMONE,
VIRENDRA MAHESH,
Preview
|
PDF (444KB)
|
|
摘要:
ObjectiveTo evaluate the anxiolytic 3α-5α-reduced progesterone metabolite allopregnanolone in the luteal phase of the menstrual cycle in women with premenstrual syndrome (PMS) and controls.MethodsThirty-five women with prospectively documented PMS and 36 controls were evaluated. Serum progesterone and allopregnanolone levels were measured on days 19 and 26 of the cycle as determined by urinary LH detection kits. Analysis of variance and Studentttests were used to analyze the data.ResultsAllopregnanolone levels were significantly lower on day 26 in the PMS group than in controls (3.6 ± 0.8 versus 7.5 ± 1.3 ng/mL;P<.04). Significant differences in the ratio of the metabolite to progesterone also were noted, with a smaller ratio in the PMS subjects (0.9 ± 0.3 versus 3.2 ± 1.3 ng/mL;P<.05). There were no significant differences between the PMS and control groups with respect to serum progesterone levels.ConclusionSubjects with PMS manifested lower levels of the anxiolytic metabolite allopregnanolone in the luteal phase when compared with controls. Diminished concentrations of allopregnanolone in women with PMS may lead to an inability to enhance gamma aminobutyric acid-mediated inhibition during states of altered central nervous system excitability, such as ovulation or physiologic or psychological stress. The lowered metabolite levels could contribute to the genesis of various mood symptoms of the disorder, such as anxiety, tension, and depression.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
2. |
A Randomized Controlled Trial to Evaluate the Use of the Endocervical Brush After Endocervical Curettage |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 715-717
KATHLEEN TATS,
JULIE STRICKLAND,
Preview
|
PDF (253KB)
|
|
摘要:
ObjectiveTo determine if using the endocervical brush after curetting the endocervix will increase the yield of endocervical tissue retrieved for an endocervical curettage (FCC) specimen.MethodsBetween March 1, 1995, and June 30, 1996, we recruited for participation patients with abnormal Papanicolaou smears referred for colposcopy. Exclusion criteria were pregnancy, previous hysterectomy, and a history of diethylstilbestrol exposure. Colposcopy and biopsies were performed by residents under direct supervision of the attending staff. Endocervical curettages were performed using the Kevorkian endocervical curette. The subjects were then assigned randomly to one of two ways of collecting the FCC tissue: with either a curette or an endocervical brush. Specimens were reviewed by pathologists, who were blinded to the method of ECC collection.ResultsDuring the study period, 124 patients agreed to participate; 62 were assigned to the control group, and 62 to the study group. Six subjects had missing data, leaving 118 patients available for analysis. In the control group, six of the 58 FCC samples obtained contained insufficient endocervical tissue for pathologic diagnosis. None of the 60 samples from the endocervical brush group was insufficient. The difference between the two groups was statistically significant (P= .01).ConclusionThe addition of the endocervical brush to endocervical tissue sampling at colposcopy in the study decreased the number of insufficient samples. The endocervical brush method of collection of an ECC specimen from the canal after the Kevorkian curette is used is a valuable addition to this diagnostic tool. We recommend its use in obtaining an ECC specimen.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
3. |
Does Prolonged High‐impact Activity Contribute to Later Urinary Incontinence? A Retrospective Cohort Study of Female Olympians |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 718-722
INGRID NYGAARD,
Preview
|
PDF (394KB)
|
|
摘要:
ObjectiveTo determine whether women engaged in strenuous, provocative exercise are more likely to be incontinent in future life than similarly fit women who participated in less provocative exercise.MethodsIn this retrospective cohort study, female American Olympians who competed in swimming (low-impact group) and in gymnastics and track and field (high-impact group) between 1960 and 1976 completed a structured questionnaire. Primary outcome measures included the prevalence of the symptoms of stress and urge incontinence. Statistical analyses of results included χ2, Fisher exact test, two-tailedttests, Wilcoxon rank sum test, and stepwise multiple logistic regression.P<.05 was considered significant.ResultsOne hundred four women responded (response rate 51.2%). High-impact athletes were older (46.2 compared with 42.4 years) and were more likely to report incontinence when they were doing their sport as Olympians (35.8% compared with 4.5%) than low-impact athletes; low-impact athletes were more likely to be parous (83.3% compared with 60.7%). There was no difference in the prevalence of the symptom of stress incontinence between the high-versus low-impact groups: any incontinence, 41.1% compared with 50%; daily or weekly incontinence, 10.7% compared with 8.3%; and incontinence that bothered them moderately or greatly, 10.7% compared with 4.2%. With our sample size, this study had 80% power to detect a fourfold difference in daily or weekly incontinence between groups, but only a 30% power to detect a twofold difference, given a baseline prevalence of 10%. When age, body mass index (BMI), parity, Olympic sport group, and incontinence during Olympic sport were entered into stepwise logistic regression analyses, only BMI was significantly associated with regular stress or urge incontinence symptoms.ConclusionParticipation in regular, strenuous, high impact activity when younger did not predispose women to a markedly higher rate of clinically significant urinary incontinence in later life.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
4. |
Factors Affecting Detrusor Contraction Strength During Voiding in Women |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 723-726
MICKEY KARRAM,
LINDA PARTOLL,
VINCE BILOTTA,
OSCAR ANGEL,
Preview
|
PDF (286KB)
|
|
摘要:
ObjectiveTo compare voiding mechanisms in continent and stress incontinent women and to assess the effects of aging, childbirth, menopausal status, and anterior vaginal wall relaxation on detrusor contraction strength during voiding.MethodsThirty-eight asymptomatic female volunteers underwent a thorough evaluation including multichannel urodynamic testing and instrumented pressure-flow voiding studies. The voiding mechanisms and detrusor contraction strengths, available in 30 women, were compared with those of 70 women evaluated previously with objective evidence of genuine stress urinary incontinence. The effect of age, parity, bladder neck mobility, and anterior vaginal wall relaxation on maximum detrusor pressure was assessed using χ2and linear regression analyses. Detrusor pressures in premenopausal and postmenopausal women and continent and stress incontinent women were also compared.ResultsFour types of voiding mechanisms were identified. All 30 of the continent women voided with a detrusor contraction, compared with 59 (84%) of genuine stress incontinent subjects. The mean ± standard deviation [SD]) detrusor contraction was significantly stronger in continent women than incontinent women (20.3 ± 14.2 cm H2O compared with 12.3 ± 11.0 cm H2O;P<.01). In continent and incontinent subjects, maximum detrusor pressure did not correlate significantly with increasing age, parity, bladder neck mobility, or degree of anterior vaginal wall relaxation. Premenopausal women had significantly higher mean (± SD) maximum detrusor pressures than postmenopausal women (16.3 ± 13.0 cm H2O compared with 11.5 ± 11.0 cm H2O;P<.01).ConclusionWomen with genuine stress urinary incontinence may be more likely to void with a weak or absent detrusor contraction than continent women. Menopausal status was the only factor identified that significantly affected maximum detrusor pressure during voiding.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
5. |
EndothelinAReceptors in Human Uterine Leiomyomas |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 727-730
MICHELLE BREUILLER-FOUCHÉ,
MARIE-CÉCILE VACHER-LAVENU,
THÉRÈSE FOURNIER,
PHILIPPE MORICE,
JEAN-BERNARD DUBUISSON,
FRANÇOISE FERRÉ,
Preview
|
PDF (281KB)
|
|
摘要:
ObjectiveTo determine if there are endothelia receptors on human uterine leiomyomas.MethodsSamples of leiomyomas from eight patients were analyzed for [iodine (I) -125]endothelin-1 binding. Several subtype-selective ligands were used to determine the endothelia receptor population.ResultsBinding of [125I]endothelin-1 to uterine leiomyoma membranes was specific and saturable, with a mean ± dissociation constant 85.5 ± 8.4 pM. Competition binding studies showed that the order of potency was endothelia-1 > endothelia-3, which was consistent with the presence of the endothelinAreceptor subtype. Binding of [125I]endothelin-1 was displaced by an endothelinA-selective antagonist, but not by sarafotoxin 6c, an endothelinB-selective agonist. An endothelinB-selective ligand was not specifically bound to leiomyoma.ConclusionThese results indicate that only endothelinAreceptors are present in human uterine leiomyomas. We speculate that endothelia-1 may act through these endothelinAreceptors to influence the development or regulation of hypertrophy and proliferation of the human myometrium during pregnancy and in uterine disorders like leiomyomas.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
6. |
Postoperative Pain Relief Following Laparoscopic Tubal Sterilization With Silastic Bands |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 731-734
AUDREY TOOL,
DOROTHY KAMMERER-DOAK,
CUONG NGUYEN,
MARY COUSIN,
MARGARET CHARSLEY,
Preview
|
PDF (292KB)
|
|
摘要:
ObjectiveTo evaluate postoperative pain relief of intramuscular ketorolac, topical bupivacaine, and placebo in patients undergoing laparoscopic tubal sterilization with silastic bands.MethodsOne hundred five women undergoing laparoscopic tubal sterilization with silastic bands were randomized to one of three groups: one received intramuscular ketorolac and topical placebo applied to the fallopian tubes, the second received intramuscular placebo and topical bupivacaine, and the third received intramuscular placebo and topical placebo. Surgical procedures, anesthesia, and recovery were conducted with standardized protocols. Postoperative pain perception was graded using the modified McGill pain intensity scale at 30 minutes postoperatively, at discharge from the recovery room, and the next morning by telephone interview. Other measured variables included postoperative vomiting, additional analgesia requirement, and length of time spent in the recovery room.ResultsOnly topical bupivacaine was found to decrease postoperative pain scores significantly over those with placebo, at 30 minutes postoperatively (median score 2 compared with 4,P= .002) and at discharge from the recovery room (median score 2 compared with 3,P= .03). There was no significant decrease in pain scores with intramuscular ketorolac compared with placebo. No differences in pain scores were found between the three groups at the next morning phone call. There were no significant differences between the three groups with respect to requirements for supplemental pain medications in the recovery room, incidence of postoperative vomiting, or length of time spent in the recovery room.ConclusionTopical bupivacaine decreases postoperative pain scores significantly compared with placebo in women undergoing laparoscopic tubal sterilization with silastic bands.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
7. |
Vaginal Misoprostol Compared With Oral Misoprostol in Termination of Second‐Trimester Pregnancy |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 735-738
PAK-CHUNG HO,
SUK-WAI NGAI,
KA-LAI LIU,
GRACE WONG,
SHARON LEE,
Preview
|
PDF (314KB)
|
|
摘要:
ObjectiveTo compare the efficacy of vaginal with oral misoprostol in termination of second-trimester pregnancy after pretreatment with mifepristone.MethodsWomen requesting termination of secondtrimester pregnancy were randomized into two groups. Thirty-six to 48 hours after oral administration of 200 mg of mifepristone, women were given either oral or vaginal misoprostol 200 μg every 3 hours for a maximum of five doses in the first 24 hours. Women receiving oral misoprostol also were given a vaginal placebo (vitamin B6), whereas those receiving vaginal misoprostol were given an oral placebo. If they failed to abort, a second course was given by the same route.ResultsThe median induction-abortion interval in the vaginal group (9 hours) was significantly shorter than that in the oral group (13 hours). The percentage of women aborting within 24 hours in the vaginal group (90%) was significantly higher than that in the oral group (69%). The median amount of misoprostol used in the vaginal group (600 μg) also was significantly less than that in the oral group (1000 μg). There was no significant difference in the incidence of side effects between the two groups except for fatigue and breast tenderness, which were more common in the oral group. Seventy-six percent of the women preferred the oral route, and 24.5% of the women preferred the vaginal route.ConclusionVaginal misoprostol is more effective than oral misoprostol in termination of second-trimester pregnancy after pretreatment with mifepristone, but more women preferred the oral route.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
8. |
Cervicovaginal Human Immunodeficiency Virus Secretion and Plasma Viral Load in Human Immunodeficiency Virus–Seropositive Women |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 739-743
SUSAN UVIN,
ANGELA CALIENDO,
Preview
|
PDF (397KB)
|
|
摘要:
ObjectiveTo evaluate human immunodeficiency virus (HIV)-1 RNA burden in paired plasma and cervicovaginal lavage specimens and to assess the relation of plasma HIV-1 RNA level, CD4 cell count, and antiretroviral therapy with cervicovaginal HIV-1 viral load.MethodsPaired blood and cervicovaginal lavage specimens were collected from 72 HIV-infected women. Quantitation of HIV-1 RNA from plasma and cervicovaginal lavage specimens was performed by using the nucleic acid sequencebased amplification assay. Analyses examined relations between cervicovaginal HIV-1 RNA and plasma HIV-1 RNA level, CD4 count, and antiretroviral therapy.ResultsPlasma HIV-1 RNA was detectable in 61 of 72 women (85%), with copy numbers ranging from 330 to 1,600,000 copies/mL. Twenty-eight of 72 (39%) had detectable HIV-1 RNA in cervicovaginal lavage specimens, ranging from 320 to 440,000 copies/mL. The cervicovaginal lavage HIV-1 RNA level was detectable in 9%, 29%, 52%, and 53% of the women with plasma HIV-1 RNA of less than 400, 400–9999, 10,000–100,000, and more than 100,000 copies, respectively (P= .043). Among women with CD4 counts of less than 200, 200–500, and greater than 500/mm3, cervicovaginal lavage HIV-1 RNA was detected in 67%, 32%, and 25% of subjects, respectively (P= .018). Among women receiving antiretroviral therapy, cervicovaginal lavage revealed HIV-1 RNA in 67%, 31%, and 25% with CD4 cell counts of less than 200, 200–500, and more than 500/mm3, respectively (P= .042).ConclusionThe presence of HIV-1 RNA in cervicovaginal lavage correlates significantly with the level of HIV-1 RNA in plasma and negatively with CD4 cell count.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
9. |
Acetowhitening of the Cervix and Vulva as a Predictor of Subclinical Human Papillomavirus InfectionSensitivity and Specificity in a Population‐Based Study |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 744-747
MONICA JONSSON,
ROGER KARLSSON,
MAGNUS EVANDER,
ÅKE GUSTAVSSON,
EVA RYLANDER,
GÖRAN WADELL,
Preview
|
PDF (295KB)
|
|
摘要:
ObjectiveTo evaluate acetowhite changes of the cervix and vulva as a predictor of human papillomavirus (HPV) infection.MethodsIn this population-based study all women aged 19, 21, 23, and 25 years and registered as living in a primary health care area within the city of Umeå, Sweden were eligible for inclusion. Each participant underwent a gynecologic examination with sampling of epithelial cells for HPV-DNA detection and Papanicolaou smear. Colposcopy was performed 5 minutes after application of 5% acetic acid. A two-step polymerase chain reaction (PCR) technique was employed for HPV-DNA detection.ResultsColposcopy and sampling of epithelial cells could be performed in 535 women. The sensitivity of detection of HPV infection by the acetowhitening of the cervix was 22% (95% confidence interval [CII 18%, 26%). The specificity of detection of HPV infection by the acetowhitening of the cervix was 90% (95% CI 87%, 93%). The sensitivity of detection of HPV infection by cytology was 73% (95% CI 10%, 16%), and the specificity was 99% (95% CI 98%, 100%). The combination of acetowhitening and cytology did not improve the diagnostic value.ConclusionAcetowhitening of the cervix and vulva has low sensitivity as a predictor of HPV infections as determined by PCR.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
10. |
Human Papillomavirus Type 16 and Risk of Preinvasive and Invasive Vulvar CancerResults From a Seroepidemiological Case‐control Study |
|
Obstetrics & Gynecology,
Volume 90,
Issue 5,
1997,
Page 748-754
ALLAN HILDESHEIM,
CHENG-LONG HAN,
LOUISE BRINTON,
ROBERT KURMAN,
JOHN SCHILLER,
Preview
|
PDF (574KB)
|
|
摘要:
ObjectiveTo examine whether human papillomavirus (HPV) type 16 is involved in the etiology of vulvar carcinomas.MethodsWe studied 142 histologically confirmed cases of vulvar intraepithelial neoplasia (VIN) grade 3 and invasive vulvar cancer and 126 community controls. In addition to a detailed questionnaire through which we obtained information on putative risk factors for vulvar cancer, blood samples were collected from participating subjects and tested for the presence of antibodies to HPV-16 virus-like particles. Data were analyzed by logistic regression.ResultsSubjects positive for HPV-16 antibodies were at a 5.3-fold increased risk of vulvar neoplasia (95% confidence interval [CI] 2.5, 11.1), and subjects with high antibody levels were at a 20-fold increased risk of disease (95% CI 5.4, 76.7). A stronger association between HPV-16 seropositivity and disease was observed for VIN grade 3 (odds ratio [OR] 13.4; 95% CI 3.9, 46.5) than for invasive disease (OR 2.9; 95% CI 0.94, 8.7), and for invasive tumors, there was a suggestion that the association was stronger for women diagnosed with squamous carcinoma of basaloid and/or warty types (OR 3.8; 95% CI 0.76, 18.9) than for those diagnosed with keratinizing squamous cell carcinomas (OR 1.6; 95% CI 0.35, 7.4). Number of sexual partners and herpes simplex virus type 2 seropositivity remained as independent risk factors for vulvar neoplasia after control for confounding by HPV-16. The risk associated with HPV-16 seropositivity was higher among smokers (OR 8.5; 95% CI 3.8, 19) than among nonsmokers (OR 3.4; 95% CI 0.85, 13).ConclusionOur results confirm that HPV is associated with vulvar carcinomas. Findings also suggest the possibility that other sexually transmitted agents might be involved in the etiology of some vulvar tumors and that smoking may be an important cofactor involved in the etiology of HPVrelated vulvar tumors. Evaluation of the role of HPV types other than HPV-16 in the etiology of vulvar cancer is needed, and additional efforts aimed at further elucidating the role of smoking and other cofactors in this disease process are warranted.
ISSN:0029-7844
出版商:OVID
年代:1997
数据来源: OVID
|
|